<p>Supplemental material, HPX791509_Supplemental_material_CLN for A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs by Mackenzie Prokes and Adam Root in Hospital Pharmacy</p
<p>Supplemental material for Levosimendan in pulmonary hypertension and right heart failure by Mona ...
<p>Supplemental material, Appendices_HPX_769570 for Evaluation of a Multidisciplinary Pain, Agitatio...
Supplemental material, sj-docx-1-hpx-10.1177_00185787231196428 for Impact of Iron Supplementation on...
Supplemental material for Efficacy and safety of oral targeted therapies in pulmonary arterial hyper...
<p>Supplemental material for Validation of claims-based algorithms for pulmonary arterial hypertensi...
Supplemental material, Supplemental Material3 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material, AOP823330_Supplemental_Material_CLN for Cardiovascular Risk Reduction in the ...
Supplemental material, Supplemental Material1 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material, Supplemental_Material_1 for Patient Perception of Physicians and Medication A...
Supplemental material, Supplemental Material2 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material for Clinical and genetic associations with prostacyclin response in pulmonary ...
Supplemental material, sj-docx-1-pmt-10.1177_87551225231199358 for Drug-Related Problems and Pharmac...
Supplemental material, sj-docx-1-pmt-10.1177_87551225231199358 for Drug-Related Problems and Pharmac...
Supplemental material, Supplemental_Tables_18.09.12 for Patient expectations of hypertension and dia...
Supplemental material for Implementation and evaluation of high-dose methotrexate administration gui...
<p>Supplemental material for Levosimendan in pulmonary hypertension and right heart failure by Mona ...
<p>Supplemental material, Appendices_HPX_769570 for Evaluation of a Multidisciplinary Pain, Agitatio...
Supplemental material, sj-docx-1-hpx-10.1177_00185787231196428 for Impact of Iron Supplementation on...
Supplemental material for Efficacy and safety of oral targeted therapies in pulmonary arterial hyper...
<p>Supplemental material for Validation of claims-based algorithms for pulmonary arterial hypertensi...
Supplemental material, Supplemental Material3 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material, AOP823330_Supplemental_Material_CLN for Cardiovascular Risk Reduction in the ...
Supplemental material, Supplemental Material1 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material, Supplemental_Material_1 for Patient Perception of Physicians and Medication A...
Supplemental material, Supplemental Material2 for Health Canada’s Use of its Notice of Compliance Wi...
Supplemental material for Clinical and genetic associations with prostacyclin response in pulmonary ...
Supplemental material, sj-docx-1-pmt-10.1177_87551225231199358 for Drug-Related Problems and Pharmac...
Supplemental material, sj-docx-1-pmt-10.1177_87551225231199358 for Drug-Related Problems and Pharmac...
Supplemental material, Supplemental_Tables_18.09.12 for Patient expectations of hypertension and dia...
Supplemental material for Implementation and evaluation of high-dose methotrexate administration gui...
<p>Supplemental material for Levosimendan in pulmonary hypertension and right heart failure by Mona ...
<p>Supplemental material, Appendices_HPX_769570 for Evaluation of a Multidisciplinary Pain, Agitatio...
Supplemental material, sj-docx-1-hpx-10.1177_00185787231196428 for Impact of Iron Supplementation on...